Target intelligence / Profile preview

Bacterial 70S ribosomal subunit (70S ribosome)

Target
70S ribosome
Molecular classification
Ribosome, Ribonucleoprotein complex, Enzyme (peptidyl transferase activity as part of the 50S subunit), Other
01

Overview

The bacterial 70S ribosomal subunit is a large ribonucleoprotein complex essential for protein synthesis in prokaryotes, composed of a small (30S) and a large (50S) subunit. The 30S subunit contains 16S rRNA and 21 proteins, while the 50S contains 23S and 5S rRNA and 34–36 proteins. The ribosome's main function is to catalyze mRNA-directed polymerization of amino acids into polypeptide chains, making it the central hub of translation and a critical target for many antibiotics. Numerous clinically important antibiotics act by binding to the 70S ribosome to inhibit various steps in translation, such as initiation, elongation, or termination. Targeting the bacterial ribosome allows selective inhibition of bacterial protein synthesis, but the high degree of rRNA and protein conservation across species requires careful drug design to maintain selectivity and prevent toxicity. Resistance frequently arises through mutation of ribosomal genes or acquisition of protective enzymes.

Other names
Prokaryotic ribosome70S ribosomeBacterial ribosome
02

Mechanism of action

Inhibition of peptide bond formation (50S subunit inhibitors such as macrolides, chloramphenicol); Inhibition of translation initiation or mRNA/tRNA translocation (30S subunit inhibitors such as aminoglycosides, kasugamycin, tetracyclines); Binding to ribosomal RNA or proteins, blocking functional sites or assembly

03

Biological functions

Protein synthesismRNA translationPeptidyl transferase activityMaintenance of genetic code fidelity
04

Disease associations

Infection (especially bacterial infections)Other (antibiotic resistance development)
05

Safety considerations

Selectivity: Drugs must target the bacterial ribosome without affecting eukaryotic (mitochondrial/cytosolic) ribosomes to avoid toxicityEmergence of antibiotic resistance via target modification or effluxOff-target effects leading to mitochondrial toxicity for some ribosome inhibitors (e.g., chloramphenicol)
06

Interacting drugs

Aminoglycosides (e.g., paromomycin, neomycin)

10 more in the full profile.

07

Biomarkers

Mutations in 16S or 23S rRNA (conferring resistance to specific antibiotics, e.g., aminoglycoside or macrolide resistance)Ribosomal protein modifications (less commonly used directly in clinical practice)

Beyond the preview

Go deeper on Bacterial 70S ribosomal subunit (70S ribosome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 70S ribosomal subunit (70S ribosome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call